Sustained virological response to peginterferon plus ribavirin in chronic hepatitis C genotype 1 patients is associated with a persistent Th1 immune response

Alimentary Pharmacology and Therapeutics

Volumn 24, Issue 1, 2006, Pages 117-128

  Trapero Marugan M ^a   Garcia Buey L ^a   Munoz C ^a   Quintana, N E ^a   Moreno Monteagudo, J A ^a   Borque, M J ^a   Fernandez M J ^b   Salvanes F R ^b   Medina, J ^a   Moreno Otero, R ^a  

^a HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 4; PEGINTERFERON ALPHA2A; PHORBOL ESTER; RIBAVIRIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BLOOD CELL; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG RESPONSE; FLOW CYTOMETRY; FOLLOW UP; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNE RESPONSE; LONGITUDINAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RELAPSE; TH1 CELL; TH2 CELL;

ADULT; ANTIVIRAL AGENTS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CYTOKINES; DRUG THERAPY, COMBINATION; GENOTYPE; HEPATITIS C, CHRONIC; HUMANS; IMMUNITY, CELLULAR; INTERFERON ALFA-2A; LONGITUDINAL STUDIES; MIDDLE AGED; POLYETHYLENE GLYCOLS; PROSPECTIVE STUDIES; RIBAVIRIN; TH1 CELLS; TREATMENT OUTCOME; VIRAL LOAD;

EID: 33745177282     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2006.02954.x     Document Type: Article

References (39)

1. Kamal SM Ismail A Graham CS, et al. Pegylated interferon alpha therapy in acute hepatitis C: relation to hepatitis C virus-specific T cell response kinetics. Hepatology 2004 39 : 1721 31.
2. Mondelli MU Cerino A Cividini A. Acute hepatitis C: diagnosis and management. J Hepatol 2005 42 ( Suppl. S108 14.
3. Mondelli MU Cerino A Meola A Nicosia A. Variability or conservation of hepatitis C virus hypervariable region 1? Implications for immune responses. J Biosci 2003 28 : 305 10.
4. Rehermann B. Interaction between the hepatitis C virus and the immune system. Semin Liver Dis 2000 20 : 127 41.
5. Lee S Macquillan GC Keane NM, et al. Immunological markers predicting outcome in patients with hepatitis C treated with interferon-alpha and ribavirin. Immunol Cell Biol 2002 80 : 391 7.
6. Lechner F Wong DK Dunbar PR, et al. Analysis of successful immune responses in persons infected with hepatitis C virus. J Exp Med 2000 191 : 1499 512.
7. Penna A Missale G Lamonaca V, et al. Intrahepatic and circulating HLA class II-restricted, hepatitis C virus-specific T cells: functional characterization in patients with chronic hepatitis C. Hepatology 2002 35 : 1225 36.
8. Schirren CA Jung MC Gerlach JT, et al. Liver-derived hepatitis C virus (HCV)-specific CD4(+) T cells recognize multiple HCV epitopes and produce interferon gamma. Hepatology 2000 32 : 597 603.
9. Reiser M Marousis CG Nelson DR, et al. Serum interleukin 4 and interleukin 10 levels in patients with chronic hepatitis C virus infection. J Hepatol 1997 26 : 471 8.
10. Neuman MG Blendis LM Shear NH, et al. Cytokine network in nonresponding chronic hepatitis C patients with genotype 1: role of triple therapy with interferon alpha, ribavirin, and ursodeoxycholate. Clin Biochem 2001 34 : 183 8.
11. Brinkmann V Geiger T Alkan S Heusser CH. Interferon alpha increases the frequency of interferon gamma-producing human CD4+ T cells. J Exp Med 1993 178 : 1655 63.
12. Bozkaya H Bozdayi AM Aslan N, et al. Circulating IL-2 and IL-10 in chronic active hepatitis C with respect to the response to IFN treatment. Infection 2000 28 : 309 13.
13. Day CL Walker BD. Progress in defining CD4 helper cell responses in chronic viral infections. J Exp Med 2003 198 : 1773 7.
14. Marinho RT Pinto RM Santos ML de Moura MC. Lymphocyte T helper-specific reactivity in sustained responders to interferon and ribavirin with negativization (seroreversion) of anti-hepatitis C virus. Liver Int 2004 24 : 413 8.
15. Garcia-Monzon C Moreno-Otero R Pajares JM, et al. Expression of a novel activation antigen on intrahepatic CD8+ T lymphocytes in viral chronic active hepatitis. Gastroenterology 1990 98 : 1029 35.
16. Amati L Caradonna L Magrone T, et al. Modifications of the immune responsiveness in patients with hepatitis C virus infection following treatment with IFN-alpha/ribavirin. Curr Pharm Des 2002 8 : 981 93.
17. Chang KM. Immunopathogenesis of hepatitis C virus infection. Clin Liver Dis 2003 7 : 89 105.
18. Francavilla V Accapezzato D De Salvo M, et al. Subversion of effector CD8+ T cell differentiation in acute hepatitis C virus infection: exploring the immunological mechanisms. Eur J Immunol 2004 34 : 427 37.
19. Shinohara M Ishii K Takamura N. Long-term changes of peripheral blood CD4-positive T cell subsets (Th1, Th2) in chronic hepatitis C patients with a sustained response or no response to IFN. Hepatol Res 2003 27 : 260 5.
20. MacDonald AJ Duffy M Brady MT, et al. CD4 T helper type 1 and regulatory T cells induced against the same epitopes on the core protein in hepatitis C virus-infected persons. J Infect Dis 2002 185 : 720 7.
21. Mondelli MU. Multifaceted functions of B cells in chronic hepatitis C virus infection. Antiviral Res 2003 60 : 111 5.
22. Kamal SM Fehr J Roesler B Peters T Rasenack JW. Peginterferon alone or with ribavirin enhances HCV-specific CD4 T-helper 1 responses in patients with chronic hepatitis C. Gastroenterology 2002 123 : 1070 83.
23. Sreenarasimhaiah J Jaramillo A Crippin J Lisker-Melman M Chapman WC Mohanakumar T. Concomitant augmentation of type 1 CD4+ and CD8+ T-cell responses during successful interferon-alpha and ribavirin treatment for chronic hepatitis C virus infection. Hum Immunol 2003 64 : 497 504.
24. Chang KM Thimme R Melpolder JJ, et al. Differential CD4(+) and CD8(+) T-cell responsiveness in hepatitis C virus infection. Hepatology 2001 33 : 267 76.
25. Accapezzato D Francavilla V Paroli M, et al. Hepatic expansion of a virus-specific regulatory CD8(+) T cell population in chronic hepatitis C virus infection. J Clin Invest 2004 113 : 963 72.
26. Accapezzato D Francavilla V Rawson P, et al. Subversion of effector CD8+ T cell differentiation in acute hepatitis C virus infection: the role of the virus. Eur J Immunol 2004 34 : 438 46.
27. Morishima C Musey L Elizaga M, et al. Hepatitis C virus-specific cytolytic T cell responses after antiviral therapy. Clin Immunol 2003 108 : 211 20.
28. Barnes E Harcourt G Brown D, et al. The dynamics of T-lymphocyte responses during combination therapy for chronic hepatitis C virus infection. Hepatology 2002 36 : 743 54.
29. Eckels DD Tabatabail N Bian TH, et al. In vitro human Th-cell responses to a recombinant hepatitis C virus antigen: failure in IL-2 production despite proliferation. Hum Immunol 1999 60 : 187 99.
30. Manns MP McHutchison JG Gordon SC, et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet 2001 358 : 958 65.
31. Fried MW Shiffman ML Reddy KR, et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 2002 347 : 975 82.
32. Hadziyannis SJ Sette H Jr. Morgan TR, et al. Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose. Ann Intern Med 2004 140 : 346 55.
33. Lohr HF Gerken G Roth M Weyer S Schlaak JF Meyer zum Buschenfelde KH. The cellular immune responses induced in the follow-up of interferon-alpha treated patients with chronic hepatitis C may determine the therapy outcome. J Hepatol 1998 29 : 524 32.
34. Cramp ME Rossol S Chokshi S Carucci P Williams R Naoumov NV. Hepatitis C virus-specific T-cell reactivity during interferon and ribavirin treatment in chronic hepatitis C. Gastroenterology 2000 118 : 346 55.
35. Rahman F Heller T Sobao Y, et al. Effects of antiviral therapy on the cellular immune response in acute hepatitis C. Hepatology 2004 40 : 87 97.
36. Lancaster T Sanders E Christie JM Brooks C Green S Rosenberg WM. Quantitative and functional differences in CD8+ lymphocyte responses in resolved acute and chronic hepatitis C virus infection. J Viral Hepat 2002 9 : 18 28.
37. Lau JY Tam RC Liang TJ Hong Z. Mechanism of action of ribavirin in the combination treatment of chronic HCV infection. Hepatology 2002 35 : 1002 9.
38. Tam RC Pai B Bard J, et al. Ribavirin polarizes human T cell responses towards a type 1 cytokine profile. J Hepatol 1999 30 : 376 82.
39. Zeuzem S Herrmann E Lee JH, et al. Viral kinetics in patients with chronic hepatitis C treated with standard or peginterferon alpha2a. Gastroenterology 2001 120 : 1438 47.